DOM
DOM (STP) is a long-lasting synthetic psychedelic amphetamine of the DOx family, active at very low doses and notorious for an extremely long duration that has historically led to accidental overdose and prolonged, distressing trips. It is a Schedule I controlled substance in the US.
Overview
DOM, also called STP, is a synthetic psychedelic of the substituted-amphetamine (DOx) family, first synthesized by Alexander Shulgin. It gained infamy in the late 1960s San Francisco scene, where tablets far stronger than users expected caused a wave of overdoses and bad trips. It is a potent, long-acting psychedelic rather than a stimulant in the recreational sense, and its very long duration is central to its risk profile.
Source: DEA; peer-reviewed literature (NIH/PMC); Wikipedia (CC-BY-SA)
Chemistry & mechanism of action
DOM is a serotonergic psychedelic that acts primarily as an agonist at serotonin 5-HT2A receptors, the receptor target shared by classic psychedelics such as LSD and psilocin. This 5-HT2A activation drives its hallucinogenic effects. Compared with many psychedelics it is unusually potent by weight and unusually slow to clear, which is why its effects persist far longer than a typical psychedelic experience.
Source: peer-reviewed literature (NIH/PMC); Wikipedia (CC-BY-SA)
Effects
Effects include visual distortions, altered thought and perception, emotional intensity, and stimulation. The defining feature is duration: a DOM experience can last well over half a day, far longer than LSD or psilocybin, so someone who assumes a shorter trip can be overwhelmed. Slow onset also invites redosing before the first amount is felt, which can push the experience into frightening territory.
Source: peer-reviewed literature (NIH/PMC); Wikipedia (CC-BY-SA)
Risks & harms
DOM's signature dangers flow from its potency and its extreme duration. Because active amounts are tiny, the margin between a manageable and an overwhelming experience is narrow, and the drug's history is defined by accidental overdose when tablets contained more than expected. An experience lasting many hours longer than anticipated can produce prolonged panic, confusion, and inability to function, and the slow onset drives dangerous redosing. At higher exposures DOM can cause a stimulant-like strain on the body: raised heart rate and blood pressure, and in serious cases vasoconstriction and hyperthermia. As with any illicit tablet or powder, there is no way to confirm identity, dose, or purity without testing, and substances sold as one psychedelic are frequently something else entirely. Difficult psychological reactions can be worsened by an unsafe environment. Anyone experiencing chest pain, a dangerously high temperature, seizures, or a severe psychiatric crisis needs emergency care — call 911, and Poison Control at 1-800-222-1222 can advise on exposures. This page has not yet been medically reviewed.
Source: DEA; peer-reviewed literature (NIH/PMC); SAMHSA
Legal status (US)
In the United States, DOM is a Schedule I controlled substance, the federal category for substances treated as having no accepted medical use and a high potential for abuse. It has been federally controlled since the Controlled Substances Act era, and this applies nationwide with strict penalties for manufacture, distribution, and possession. Internationally it is controlled under the UN Convention on Psychotropic Substances. Follow local law; consult DEA resources for specifics. This page has not yet been medically reviewed.
Source: DEA; US federal law; UN Convention on Psychotropic Substances
Drug laws and enforcement change and vary by country. This is not legal advice. Always confirm with the destination’s embassy or official drug authority before traveling — penalties can be severe, including imprisonment.
Before you travel
Verify current rules with the destination country’s official drug authorityand your own country’s embassy before traveling. Find the destination’s U.S. embassy & official country guidance →
Non-U.S. travelers: check your own government’s travel advisory and embassy.
If you’re detained or arrested abroad
Contact your own country’s embassy or consulatein the destination immediately — notthe destination’s authorities. U.S. citizens: contact the nearest U.S. embassy/consulate and the U.S. State Department at +1-202-501-4444 (from abroad). If a U.S. citizen is arrested or detained abroad →
Images
Visual references coming soon.
If it’s too intense
If an experience becomes overwhelming, the goal is to stay safe and let it pass — most difficult experiences ease as the drug wears off.
- Get to a calm, safe space with someone you trust who is sober and can stay with you.
- Cool down if you’re overheating — move somewhere cool, remove extra layers, rest. Overheating is especially a risk with stimulants and MDMA.
- Sip water to thirst — but don’t over-hydrate. Drinking large amounts of plain water (especially after MDMA) can dangerously dilute your blood sodium (hyponatremia). Electrolytes help more than volume.
- Slow your breathing — long, slow exhales help settle a racing heart and anxiety.
- A sugary drink, fruit juice, or a snack can ease shakiness and the anxiety that comes with low blood sugar.
- Do not take more, and do not add another substance to manage it. Redosing or adding something else (including a sedative like a benzodiazepine) can make things worse, not better.
With psychedelics, fear and confusion are usually temporary. Change your surroundings — calmer light, quiet music, a trusted person — and remind yourself it will lift as the drug wears off.
Source: general harm-reduction guidance from SAMHSA, NIH/NIDA, and MedlinePlus, in our own words. Draft — not yet medically reviewed.
Forensic dossier
Draft · every field is source-cited or marked “Unknown — pending review”Identity
- PubChem CID
- 85875PubChem PUG-REST ↗ · retrieved 2026-06-18
- IUPAC name
- 1-(2,5-dimethoxy-4-methylphenyl)propan-2-aminePubChem PUG-REST ↗ · retrieved 2026-06-18
- Molecular formula
- C12H19NO2PubChem PUG-REST ↗ · retrieved 2026-06-18
- SMILES
- CC1=CC(=C(C=C1OC)CC(C)N)OCPubChem PUG-REST ↗ · retrieved 2026-06-18
- InChIKey
- NTJQREUGJKIARY-UHFFFAOYSA-NPubChem PUG-REST ↗ · retrieved 2026-06-18
- Synonyms / aliases
- STP, STP (hallucinogen), (RS)-DOM, 2,5-Dimethoxymethylamphetamine, (+-)-DOM, DEA No. 7395, Racemic DOM, DOM,R(-), NTJQREUGJKIARY-UHFFFAOYSA-NPubChem PUG-REST + seed aliases ↗ · retrieved 2026-06-18
Composition
- Composition
- N/A — single compound (see Identity)
Physical / pill characteristics
- Dosage form
- Unknown — pending review
- Route
- Unknown — pending review
- Shape
- Unknown — pending review (verify tablet imprint/shape against NLM Pillbox/DailyMed; N/A if not an oral tablet)
- Color
- Unknown — pending review (verify tablet imprint/shape against NLM Pillbox/DailyMed; N/A if not an oral tablet)
- Imprint
- Unknown — pending review (verify tablet imprint/shape against NLM Pillbox/DailyMed; N/A if not an oral tablet)
- Score
- Unknown — pending review (verify tablet imprint/shape against NLM Pillbox/DailyMed; N/A if not an oral tablet)
Scheduling & legal status
- US schedule
- Unknown — pending review
- International
- See EMCDDA/EUDA + WHO — synthesize per jurisdictionEMCDDA / EUDA ↗ · retrieved 2026-06-18
Effects
- Effects
- Cited source pending synthesis — author in our words from NIDA/MedlinePlus on review (NOT auto-generated)NIDA + MedlinePlus ↗ · retrieved 2026-06-18
Risks
- Risks
- Cited source pending synthesis — author in our words from NIDA/MedlinePlus on review (NOT auto-generated)NIDA + MedlinePlus ↗ · retrieved 2026-06-18
Interactions
- Interactions
- See DailyMed label §Drug Interactions (Rx) — synthesize + cite per itemDailyMed SPL §Drug Interactions ↗ · retrieved 2026-06-18
Dosage
Pending medical reviewer
